Bio-key International, Inc. (NASDAQ: BKYI) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $2.2 million.

For earnings history and earnings-related data on Bio-key International, Inc. (BKYI) click here.